CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's Leverage Ratio

ORMP's quarterly Leverage Ratio and Total Liabilities, Equity growth




ORMP Leverage Ratio (May 31 2020)
III. Quarter
(Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
Y / Y Equity Change 58.24 % -36.52 % -40.54 % -37.67 % 29.42 %
Y / Y Total Liabilities Change 321.96 % 399.89 % 314.83 % -6.23 % -84.26 %
Leverage Ratio MRQ 0.35 0.85 0.81 0.79 0.13
Overall Ranking # # # # #
Seq. Equity Change 112.01 % -6.24 % -11.51 % -10.04 % -14.96 %
Seq. Total Liabilities Change -12.69 % -1.33 % -9.13 % 439 % 3.43 %



Leverage Ratio third quarter 2020 Comment
Due to repayements of liabilities of -12.69% Oramed Pharmaceuticals Inc improved Leverage Ratio in third quarter 2020 to 0.35, below company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry Oramed Pharmaceuticals Inc achieved lowest Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ORMP Customers?
Leverage Ratio third quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 3
Overall Market # 22


Leverage Ratio Statistics
High Average Low
1.08 0.38 0.02
(May 31 2018)   (Feb 28 2014)




Financial Statements
Oramed Pharmaceuticals Inc 's Equity $ 34 Millions Visit ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Total Liabilities $ 12 Millions Visit ORMP's Balance sheet
Source of ORMP's Sales Visit ORMP's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingMay 31 2020, within Major Pharmaceutical Preparations Industry Leverage RatioMay 31 2020 MRQ Total LiabilitiesMay 31 2020 MRQ Equity
Abbott Laboratories  0.95 $ 29,363.000  Millions$ 30,798.000  Millions
Cyclerion Therapeutics Inc   0.94 $ 61.937  Millions$ 66.101  Millions
Retrophin Inc   0.91 $ 291.449  Millions$ 318.645  Millions
Ultragenyx Pharmaceutical Inc   0.89 $ 618.454  Millions$ 695.587  Millions
Innoviva inc   0.86 $ 422.712  Millions$ 492.812  Millions
Ampio Pharmaceuticals inc   0.83 $ 5.246  Millions$ 6.343  Millions
Agios Pharmaceuticals Inc   0.74 $ 410.695  Millions$ 558.465  Millions
Alexion Pharmaceuticals Inc   0.59 $ 6,212.400  Millions$ 10,490.800  Millions
Alkermes Plc   0.59 $ 622.172  Millions$ 1,061.846  Millions
Elanco Animal Health Inc  0.47 $ 3,158.600  Millions$ 6,651.900  Millions
Opko Health Inc   0.46 $ 735.391  Millions$ 1,588.343  Millions
Blueprint Medicines Corporation  0.41 $ 236.090  Millions$ 581.367  Millions
Vertex Pharmaceuticals Inc  0.36 $ 2,697.125  Millions$ 7,519.242  Millions
Oramed Pharmaceuticals Inc   0.35 $ 11.954  Millions$ 34.112  Millions
United Therapeutics Corporation  0.34 $ 1,064.700  Millions$ 3,093.700  Millions
Macrogenics Inc   0.32 $ 79.808  Millions$ 247.784  Millions
Corvus Pharmaceuticals Inc   0.26 $ 13.337  Millions$ 50.840  Millions
Uniqure N v   0.21 $ 54.861  Millions$ 265.505  Millions
Aravive Inc   0.19 $ 11.566  Millions$ 59.447  Millions
Minerva Neurosciences inc   0.16 $ 9.223  Millions$ 56.944  Millions
Immunic Inc   0.10 $ 7.674  Millions$ 78.685  Millions
Glycomimetics Inc   0.09 $ 12.600  Millions$ 145.752  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DHR's Profile

Stock Price

DHR's Financials

Business Description

Fundamentals

Charts & Quotes

DHR's News

Suppliers

DHR's Competitors

Customers & Markets

Economic Indicators

DHR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071